Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015253
Filing Date
2023-04-27
Accepted
2023-04-27 16:03:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A impl_defa_14a_2023.htm DEFA14A 18970
2 GRAPHIC img170651140_0.jpg GRAPHIC 89999
3 GRAPHIC img170651140_1.jpg GRAPHIC 53298
  Complete submission text file 0000950170-23-015253.txt   217668
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

EIN.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: DEFA14A | Act: 34 | File No.: 001-40353 | Film No.: 23856689
SIC: 2834 Pharmaceutical Preparations